Hydrocortamate
Chemical compound
Clinical data | |
---|---|
Trade names | Magnacort, Ulcort |
Other names | 11β,17α-Dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate |
Routes of administration | Topical |
Pharmacokinetic data | |
Excretion | Hepatic |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
PubChem SID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.877 |
Chemical and physical data | |
Formula | C27H41NO6 |
Molar mass | 475.626 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Hydrocortamate (brand names Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties.[1][2] It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.[3]
References
- v
- t
- e
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids